News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
311,819 Results
Type
Article (16211)
Company Profile (101)
Press Release (295507)
Multimedia
Podcasts (48)
Webinars (10)
Section
Business (103277)
Career Advice (492)
Deals (18137)
Drug Delivery (70)
Drug Development (44446)
Employer Resources (54)
FDA (8592)
Job Trends (7122)
News (177488)
Policy (16371)
Tag
Academia (536)
Accelerated approval (2)
Adcomms (7)
Allergies (46)
Alliances (27548)
ALS (57)
Alzheimer's disease (548)
Antibody-drug conjugate (ADC) (71)
Approvals (8661)
Artificial intelligence (163)
Autoimmune disease (11)
Automation (7)
Bankruptcy (159)
Best Places to Work (5228)
BIOSECURE Act (9)
Biosimilars (66)
Biotechnology (43)
Bladder cancer (28)
Brain cancer (19)
Breast cancer (111)
Cancer (983)
Cardiovascular disease (99)
Career advice (435)
Career pathing (15)
CAR-T (58)
Cell therapy (186)
Cervical cancer (8)
Clinical research (37761)
Collaboration (546)
Compensation (162)
Complete response letters (17)
COVID-19 (916)
CRISPR (25)
C-suite (137)
Cystic fibrosis (52)
Data (948)
Denatured (15)
Depression (20)
Diabetes (112)
Diagnostics (1917)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (77)
Drug pricing (68)
Drug shortages (12)
Duchenne muscular dystrophy (59)
Earnings (41609)
Editorial (13)
Employer branding (7)
Employer resources (48)
Events (41150)
Executive appointments (449)
FDA (9352)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (341)
Gene editing (57)
Generative AI (15)
Gene therapy (171)
GLP-1 (422)
Government (1545)
Grass and pollen (3)
Guidances (23)
Healthcare (5075)
Huntington's disease (8)
IgA nephropathy (18)
Immunology and inflammation (60)
Indications (18)
Infectious disease (966)
Inflammatory bowel disease (74)
Inflation Reduction Act (6)
Influenza (20)
Intellectual property (65)
Interviews (65)
IPO (7236)
IRA (29)
Job creations (2169)
Job search strategy (392)
Kidney cancer (6)
Labor market (13)
Layoffs (223)
Leadership (6)
Legal (3573)
Liver cancer (29)
Lung cancer (133)
Lymphoma (79)
Machine learning (2)
Management (17)
Manufacturing (192)
MASH (45)
Medical device (2928)
Medtech (2931)
Mergers & acquisitions (11209)
Metabolic disorders (346)
Multiple sclerosis (40)
NASH (17)
Neurodegenerative disease (46)
Neuropsychiatric disorders (11)
Neuroscience (839)
NextGen: Class of 2025 (1923)
Non-profit (766)
Now hiring (8)
Obesity (185)
Opinion (135)
Ovarian cancer (31)
Pain (65)
Pancreatic cancer (37)
Parkinson's disease (59)
Partnered (9)
Patents (144)
Patient recruitment (73)
Peanut (18)
People (30385)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (10913)
Phase II (16246)
Phase III (13556)
Pipeline (835)
Policy (75)
Postmarket research (1434)
Preclinical (3843)
Press Release (30)
Prostate cancer (63)
Psychedelics (13)
Radiopharmaceuticals (148)
Rare diseases (228)
Real estate (2931)
Recruiting (19)
Regulatory (12407)
Reports (16)
Research institute (682)
Resumes & cover letters (59)
Rett syndrome (2)
RNA editing (2)
RSV (13)
Schizophrenia (46)
Series A (62)
Series B (35)
Service/supplier (3)
Sickle cell disease (35)
Special edition (6)
Spinal muscular atrophy (115)
Sponsored (12)
Startups (1848)
State (2)
Stomach cancer (5)
Supply chain (35)
Tariffs (32)
The Weekly (31)
Vaccines (226)
Venture capitalists (17)
Weight loss (123)
Women's health (13)
Worklife (4)
Date
Today (81)
Last 7 days (372)
Last 30 days (1249)
Last 365 days (16235)
2025 (5470)
2024 (17173)
2023 (19024)
2022 (24346)
2021 (24862)
2020 (22804)
2019 (17675)
2018 (13928)
2017 (16221)
2016 (14922)
2015 (17590)
2014 (13904)
2013 (11622)
2012 (12560)
2011 (13031)
2010 (11886)
Location
Africa (332)
Alabama (18)
Alaska (1)
Arizona (70)
Arkansas (4)
Asia (23314)
Australia (3294)
California (2695)
Canada (1128)
China (324)
Colorado (122)
Connecticut (109)
Delaware (72)
Europe (46805)
Florida (437)
Georgia (59)
Idaho (12)
Illinois (238)
India (20)
Indiana (155)
Iowa (2)
Japan (116)
Kansas (62)
Kentucky (12)
Louisiana (1)
Maine (9)
Maryland (410)
Massachusetts (2187)
Michigan (71)
Minnesota (141)
Mississippi (1)
Missouri (35)
Montana (10)
Nebraska (12)
Nevada (21)
New Hampshire (10)
New Jersey (937)
New Mexico (8)
New York (822)
North Carolina (508)
North Dakota (4)
Northern California (1119)
Ohio (70)
Oklahoma (8)
Oregon (19)
Pennsylvania (646)
Puerto Rico (9)
Rhode Island (13)
South America (544)
South Carolina (3)
Southern California (1108)
Tennessee (40)
Texas (358)
United States (10507)
Utah (52)
Virginia (87)
Washington D.C. (33)
Washington State (214)
West Virginia (1)
Wisconsin (23)
311,819 Results for "milestone pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Complete response letters
Milestone Stock Crashes After Surprise Tachycardia Drug Rejection
Milestone Pharmaceuticals hit another bump in the road in its quest to get Cardamyst approved for paroxysmal supraventricular tachycardia when the FDA issued a Complete Response Letter on Friday.
March 28, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology
March 20, 2025
·
4 min read
Press Releases
Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil
February 20, 2025
·
5 min read
Press Releases
Milestone® Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
February 27, 2025
·
1 min read
Press Releases
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update
March 13, 2025
·
10 min read
Press Releases
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
January 14, 2025
·
6 min read
Business
Milestone Pharmaceuticals Partners with Arrhythmia Alliance on SVT Awareness
Milestone® Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, announced it will partner with Arrhythmia Alliance to raise awareness of supraventricular tachycardia.
May 22, 2024
·
7 min read
Press Releases
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
2 min read
Press Releases
Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025
February 11, 2025
·
4 min read
Press Releases
Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
January 28, 2025
·
7 min read
1 of 31,182
Next
